ORI Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals
  • Investments
  • 13

  • Portfolio
  • 5

  • Exits
  • 4

Exits

ORI Capital General Information

Description

Founded in 2015, ORI Capital is a venture capital firm based in Hong Kong. The firm seeks to invest in the healthcare industry globally.

Contact Information

Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 4727-34 Sun Hung Kai Centre
  • 30 Harbour Road
  • Hong Kong, Wan Chai
  • Hong Kong
+852 3898 0000

ORI Capital Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
AffyImmune Therapeutics 07-Oct-2021 Later Stage VC 0000 Biotechnology Clinical Trials - Phase 1 000000 0000
00 00000000 10-Dec-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 000000 0000
000000 00000000000 10-Mar-2020 00000 00000 000.00 Decision/Risk Analysis Generating Revenue 000000 0000
00 00000000 18-Mar-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 000000 0000
0000000000 0000000 28-Nov-2018 00000 00000 00.000 Biotechnology Clinical Trials - Phase 1 000000 0000
000000 0000000000 25-Oct-2018 00000 00000 000.00 Drug Delivery Generating Revenue 000000 0000
0000000 0000000000 16-Feb-2018 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 000000 0000
00000 000000000000 30-Nov-2017 00000 00000 00000 Drug Discovery Generating Revenue
Arterys 03-Nov-2017 Later Stage VC 000.00 Decision/Risk Analysis Generating Revenue
TriSalus Life Sciences 01-Feb-2017 Later Stage VC 000.00 Drug Delivery Generating Revenue 000000 0000
You’re viewing 10 of 13 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ORI Capital Exits (4)

Company Name Exit Date Exit Type Exit Size
Arterys 05-Oct-2022 Merger/Acquisition
00000 08-Apr-2021 000000000000000000 00.000
Semma Therapeutics 10-Oct-2019 Merger/Acquisition 00000
Orchard Therapeutics 31-Oct-2018 IPO 00000
To view ORI Capital’s complete exits history, request access »

ORI Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

ORI Capital Team (10)

Name Title Deals Funds Boards Office
Mark Valadao Managing Director Hong Kong, Hong Kong
Simone Song Founder & Senior Partner 00 0 0 Hong Kong, Hong Kong
Dicky To Partner Hong Kong, Hong Kong
Cathy Choi Financial Controller Hong Kong, Hong Kong
Elaine Yang Director 0 0 0 Hong Kong, Hong Kong
You’re viewing 5 of 10 team members. Get the full list »